At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several vaccines but did not vote on the influenza vaccine, as had previously been scheduled.

The U.S. Centers for Disease Control and Prevention’s vaccine panel voted to expand its recommendation for the use of respiratory syncytial virus (RSV) shots in adults with 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease,

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a vaccine against respiratory syncytial virus.